I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer
This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).
testosterone
taxane
prostatic neoplasm
combined modality therapy
antiandrogen therapy
- 0 views
- 19 Feb, 2024
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
An open-label, multi-center, single and cyclic ascending dose study of P-PSMA-101 autologous CAR-T cells in patients with mCRPC.
rimiducid
metastatic disease
metastatic hormone refractory prostate cancer
castration-resistant prostate cancer
prostate cancer
- 0 views
- 19 Feb, 2024